Precision surgery software company using AI for surgical data and analytics.
| Date | Round | Amount |
|---|---|---|
| Aug 2024 | Series C Caresyntax secured a $180M Series C extension ($80M equity plus up to $100M growth debt) to scale its AI surgery platform. | $180M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.